Combination treatment with bortezomib and thiostrepton is effective against tumor formation in mouse models of DEN/PB-induced liver carcinogenesis

Ming Wang, Marianna Halasi, Kasim Kabirov, Aryamitra Banerjee, Jennifer Landolfi, Alexander V. Lyubimov, Andrei L. Gartel

Research output: Contribution to journalShort survey

Abstract

Nanoparticle-encapsulated thiazole antibiotic, thiostrepton, has been shown to be an effective agent for inhibiting tumor growth in solid tumor models through the inhibition of proteasomal activity by the induction of apoptosis in cancer cells. Here, we show the efficacy of thiostrepton-micelles in inhibiting tumor growth in a DEN/PB-induced liver cancer model. We also demonstrate an enhanced anticancer effect of the combination treatment of thiostrepton with bortezomib, another proteasome inhibitor in this liver cancer model.

Original languageEnglish (US)
Pages (from-to)3370-3372
Number of pages3
JournalCell Cycle
Volume11
Issue number18
DOIs
StatePublished - Sep 15 2012

Keywords

  • Bortezomib
  • Combination treatment
  • DEN-PB
  • Liver cancer
  • Thiostrepton

ASJC Scopus subject areas

  • Molecular Biology
  • Developmental Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Combination treatment with bortezomib and thiostrepton is effective against tumor formation in mouse models of DEN/PB-induced liver carcinogenesis'. Together they form a unique fingerprint.

  • Cite this